Prohormones of adrenomedullin, atrial natriuretic peptide, vasopressin and endothelin to predict short- and long-term survival in community-acquired pneumonia – Results from the German competence network CAPNETZ

S. Krüger, S. Ewig, S. Giersdorf, O. Hartmann, N. Suttorp, T. Welte (Bochum, Hennigsdorf, Berlin, Germany)

Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia

Session: Risk factors and outcomes in community-acquired pneumonia
Session type: Oral Presentation
Number: 3438

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Krüger, S. Ewig, S. Giersdorf, O. Hartmann, N. Suttorp, T. Welte (Bochum, Hennigsdorf, Berlin, Germany). Prohormones of adrenomedullin, atrial natriuretic peptide, vasopressin and endothelin to predict short- and long-term survival in community-acquired pneumonia – Results from the German competence network CAPNETZ. Eur Respir J 2010; 36: Suppl. 54, 3438

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in community-acquired pneumonia – Results from the German competence network CAPNETZ Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia Year: 2011
Pro-atrial natriuretic peptide and pro-vasopressin to predict short- and long-term survival in community-acquired pneumonia Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Pro-atrial natriuretic peptide to predict short-term and long-term mortality in community-acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007
Influence of antibiotic pre-treatment on pro-atrial natriuretic peptide in community-acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008
Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP Source: Eur Respir J 2011; 37: 595-603 Year: 2011
Hyponatremia in community-acquired pneumonia due to increased vasopressin secretion – impact on mortality Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Role of atrial natiuretic factor and aldosterone in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 139s Year: 2002
The role of N-terminal pro B-type natriuretic peptide in predicting mortality of community acquired pneumonia Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis Year: 2019
N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Pro-adrenomedullin, pro-atrial natriuretic peptide and procalcitonin levels at admission in patients with community-acquired pneumonia and its correlation with risk scores Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007
Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020 Year: 2020
Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003
Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008
Does brain natriuretic peptide (BNP) at baseline influence the effects of nintedanib plus sildenafil in patients with IPF? Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019
New evidence of the effect of B-type natriuretic peptide (BNP) on human bronchi Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009